This includes decreasing the membrane expression of MHC class II, m-Dectin-1, Galectin-9 and PD-L1, while increasing the expression of Rae-1γ, which is associated with increased tumor immunogenicity [196]. The gene discussed is CD274; the disease is neoplasm.